<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE paragraph PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd"><paragraph id="IFRS03_IE87" principles="no"><paranum class="- topic/title paragraph/paranum "/><titlealts><navtitle>IE87</navtitle></titlealts><prolog><data name="standard_number" value="IFRS&#xa0;3"/><data name="paranum" value="IE87"/></prolog><body><p id="IFRS03_IE87_P0001" outputclass="keep_with_next">An entity (Purchaser) purchases a legal entity that contains:</p><ol outputclass="static" type="lower-alpha"><li id="IFRS03_IE87_a"><li_value>(a)</li_value><p>the rights to an in-process research and development project that is       developing a compound to treat diabetes and is in its final testing phase       (Project 1). Project 1 includes the historical know-how, formula       protocols, designs and procedures expected to be needed to complete the       final testing phase.</p></li><li id="IFRS03_IE87_b"><li_value>(b)</li_value><p outputclass="keep_with_next">a contract that provides outsourced clinical trials. The contract is priced       at current market rates and a number of vendors in the marketplace       could provide the same services. Therefore, the fair value associated with       this contract is nil. Purchaser has no option to renew the contract.</p></li></ol><p>No employees, other assets, other processes or other activities are transferred.</p></body></paragraph>